These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 22460766)

  • 1. Compensation for cranial spill-in into the cerebellum improves quantitation of striatal dopamine D₂/₃ receptors in rats with prolonged [¹⁸F]-DMFP infusions.
    Mille E; Cumming P; Rominger A; La Fougère C; Tatsch K; Wängler B; Bartenstein P; Böning G
    Synapse; 2012 Aug; 66(8):705-13. PubMed ID: 22460766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous competition against binding of [(18)F]DMFP and [(18)F]fallypride to dopamine D(2/3) receptors in brain of living mouse.
    Rominger A; Wagner E; Mille E; Böning G; Esmaeilzadeh M; Wängler B; Gildehaus FJ; Nowak S; Bruche A; Tatsch K; Bartenstein P; Cumming P
    Synapse; 2010 Apr; 64(4):313-22. PubMed ID: 19957365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Striatal and extrastriatal microPET imaging of D2/D3 dopamine receptors in rat brain with [¹⁸F]fallypride and [¹⁸F]desmethoxyfallypride.
    Constantinescu CC; Coleman RA; Pan ML; Mukherjee J
    Synapse; 2011 Aug; 65(8):778-87. PubMed ID: 21218455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantification of dopamine D(2/3) receptors in rat brain using factor analysis corrected [18F]Fallypride images.
    Millet P; Moulin-Sallanon M; Tournier BB; Dumas N; Charnay Y; Ibáñez V; Ginovart N
    Neuroimage; 2012 Sep; 62(3):1455-68. PubMed ID: 22659483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of D2-like dopamine receptors in the human brain with 18F-desmethoxyfallypride.
    Gründer G; Siessmeier T; Piel M; Vernaleken I; Buchholz HG; Zhou Y; Hiemke C; Wong DF; Rösch F; Bartenstein P
    J Nucl Med; 2003 Jan; 44(1):109-16. PubMed ID: 12515884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PET radiotracer development for imaging high-affinity state of dopamine D2 and D3 receptors: Binding studies of fluorine-18 labeled aminotetralins in rodents.
    Mukherjee J; Majji D; Kaur J; Constantinescu CC; Narayanan TK; Shi B; Nour MT; Pan ML
    Synapse; 2017 Mar; 71(3):. PubMed ID: 27864853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification of PET studies with the very high-affinity dopamine D2/D3 receptor ligand [11C]FLB 457: re-evaluation of the validity of using a cerebellar reference region.
    Asselin MC; Montgomery AJ; Grasby PM; Hume SP
    J Cereb Blood Flow Metab; 2007 Feb; 27(2):378-92. PubMed ID: 16736043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mapping the amphetamine-evoked changes in [11C]raclopride binding in living rat using small animal PET: modulation by MAO-inhibition.
    Pedersen K; Simonsen M; Østergaard SD; Munk OL; Rosa-Neto P; Olsen AK; Jensen SB; Møller A; Cumming P
    Neuroimage; 2007 Mar; 35(1):38-46. PubMed ID: 17223363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and evaluation in rats of the dopamine D2/3 receptor agonist 18F-AMC20 as a potential radioligand for PET.
    Shalgunov V; van Wieringen JP; Janssen HM; Fransen PM; Dierckx RA; Michel MC; Booij J; Elsinga PH
    J Nucl Med; 2015 Jan; 56(1):133-9. PubMed ID: 25476538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isoflurane anaesthesia differentially affects the amphetamine sensitivity of agonist and antagonist D2/D3 positron emission tomography radiotracers: implications for in vivo imaging of dopamine release.
    McCormick PN; Ginovart N; Wilson AA
    Mol Imaging Biol; 2011 Aug; 13(4):737-46. PubMed ID: 20680481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitation of carbon-11-labeled raclopride in rat striatum using positron emission tomography.
    Hume SP; Myers R; Bloomfield PM; Opacka-Juffry J; Cremer JE; Ahier RG; Luthra SK; Brooks DJ; Lammertsma AA
    Synapse; 1992 Sep; 12(1):47-54. PubMed ID: 1411963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positron emission tomography imaging of amphetamine-induced dopamine release in the human cortex: a comparative evaluation of the high affinity dopamine D2/3 radiotracers [11C]FLB 457 and [11C]fallypride.
    Narendran R; Frankle WG; Mason NS; Rabiner EA; Gunn RN; Searle GE; Vora S; Litschge M; Kendro S; Cooper TB; Mathis CA; Laruelle M
    Synapse; 2009 Jun; 63(6):447-61. PubMed ID: 19217025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of amphetamine on [(18)F]fallypride in vivo binding to D(2) receptors in striatal and extrastriatal regions of the primate brain: Single bolus and bolus plus constant infusion studies.
    Slifstein M; Narendran R; Hwang DR; Sudo Y; Talbot PS; Huang Y; Laruelle M
    Synapse; 2004 Oct; 54(1):46-63. PubMed ID: 15300884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [18F]desmethoxyfallypride as a novel PET radiotracer for quantitative in vivo dopamine D2/D3 receptor imaging in rat models of neurodegenerative diseases.
    Döbrössy MD; Braun F; Klein S; Garcia J; Langen KJ; Weber WA; Nikkhah G; Meyer PT
    Nucl Med Biol; 2012 Oct; 39(7):1077-80. PubMed ID: 22591915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surrogate markers for cerebral blood flow correlate with [¹⁸F]-fallypride binding potential at dopamine D(2/3) receptors in human striatum.
    Cumming P; Xiong G; la Fougère C; Rominger A; Bartenstein P; Buchholz HG; Piel M; Rösch F; Gründer G; Vernaleken I
    Synapse; 2013 Apr; 67(4):199-203. PubMed ID: 23239525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain uptake and distribution of the dopamine D3 /D2 receptor partial agonist [11 C]cariprazine: an in vivo positron emission tomography study in nonhuman primates.
    Tóth M; Varrone A; Steiger C; Laszlovszky I; Horváth A; Kiss B; Gyertyán I; Adham N; Halldin C; Gulyás B
    Synapse; 2013 May; 67(5):258-64. PubMed ID: 23238770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A modified simplified reference tissue model for the quantification of dopamine D2/3 receptors with [18F]fallypride images.
    Tsartsalis S; Moulin-Sallanon M; Dumas N; Tournier BB; Ginovart N; Millet P
    Mol Imaging; 2014; 13():. PubMed ID: 25248453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopaminergic activity in Tourette syndrome and obsessive-compulsive disorder.
    Denys D; de Vries F; Cath D; Figee M; Vulink N; Veltman DJ; van der Doef TF; Boellaard R; Westenberg H; van Balkom A; Lammertsma AA; van Berckel BN
    Eur Neuropsychopharmacol; 2013 Nov; 23(11):1423-31. PubMed ID: 23876376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of extrastriatal D2 in vivo specific binding of [¹⁸F](N-methyl)benperidol using PET.
    Eisenstein SA; Koller JM; Piccirillo M; Kim A; Antenor-Dorsey JA; Videen TO; Snyder AZ; Karimi M; Moerlein SM; Black KJ; Perlmutter JS; Hershey T
    Synapse; 2012 Sep; 66(9):770-80. PubMed ID: 22535514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NMDA antagonist effects on striatal dopamine release: positron emission tomography studies in humans.
    Kegeles LS; Martinez D; Kochan LD; Hwang DR; Huang Y; Mawlawi O; Suckow RF; Van Heertum RL; Laruelle M
    Synapse; 2002 Jan; 43(1):19-29. PubMed ID: 11746730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.